Recall checklist
Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml , EL(26)A/47
Class 3 recall — Action within 5 days. The defect is unlikely to cause harm to the patient.
- Reference
- EL(26)A/47
- Issued
- 5 Nov 2026
- Marketing authorisation holder
- Aspire Pharma Ltd
Scan for the official GOV.UK notice, or search GOV.UK for EL(26)A/47.
Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice. Printed from pharmshark.com on 21 November 2026; the notice may have changed since, so scan the QR code to check. Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.
No affected stock found
Batches as listed by the MHRA, exactly as published. Check against the GOV.UK notice before acting.
| Tropicamide 1% Eye Drops, solution in single dose containers 20 x 0.5ml EL(26)A/47 | |||||
|---|---|---|---|---|---|
| Batch number | Expiry | Pack size | Packs found | Quarantined ✓ | Initials |
| E941A | 30/04/2027* | 20 | |||
| E941B | 30/04/2027* | 20 | |||
| E941C | 30/04/2027* | 20 | |||
| Other packs found (write in) | |||||
|---|---|---|---|---|---|
| Product | Batch number | Expiry | Packs found | Quarantined ✓ | Initials |
What needs to be done
- Stop supplying the batches listed in the notice straight away.
- Quarantine any remaining stock of the batches listed in the notice.
- Return the quarantined stock to your supplier using your supplier’s approved process.
- Pharmacists: if patients or staff report a suspected adverse reaction, report it through the MHRA Yellow Card scheme.
- Read and act on the official GOV.UK notice.
Pharmshark summary, checked by Chris Dotchin. It is not the official notice: always read and act on the GOV.UK notice.